Genomic Health Market Cap:
1.126B for May 17, 2013Genomic Health Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 17, 2013 | 1.126B |
| May 16, 2013 | 1.104B |
| May 15, 2013 | 1.094B |
| May 14, 2013 | 1.074B |
| May 13, 2013 | 1.052B |
| May 10, 2013 | 1.049B |
| May 9, 2013 | 1.062B |
| May 8, 2013 | 1.088B |
| May 7, 2013 | 1.023B |
| May 6, 2013 | 1.014B |
| May 3, 2013 | 1.012B |
| May 2, 2013 | 918.30M |
| May 1, 2013 | 907.12M |
| April 30, 2013 | 917.40M |
| April 29, 2013 | 911.91M |
| April 26, 2013 | 906.49M |
| April 25, 2013 | 907.40M |
| April 24, 2013 | 895.95M |
| April 23, 2013 | 906.79M |
| April 22, 2013 | 903.48M |
| April 19, 2013 | 896.25M |
| April 18, 2013 | 882.70M |
| April 17, 2013 | 887.82M |
| April 16, 2013 | 868.85M |
| April 15, 2013 | 854.09M |
| April 12, 2013 | 873.36M |
| April 11, 2013 | 849.57M |
| April 10, 2013 | 848.37M |
| April 9, 2013 | 814.64M |
| April 8, 2013 | 823.67M |
| April 5, 2013 | 831.80M |
| April 4, 2013 | 817.35M |
| April 3, 2013 | 812.83M |
| April 2, 2013 | 838.13M |
| April 1, 2013 | 842.95M |
| March 28, 2013 | 851.68M |
| March 27, 2013 | 850.17M |
| March 26, 2013 | 804.70M |
| March 25, 2013 | 811.32M |
| March 22, 2013 | 816.14M |
| March 21, 2013 | 835.42M |
| March 20, 2013 | 839.94M |
| March 19, 2013 | 841.74M |
| March 18, 2013 | 855.29M |
| March 15, 2013 | 875.77M |
| March 14, 2013 | 875.77M |
| March 13, 2013 | 872.16M |
| March 12, 2013 | 872.46M |
| March 11, 2013 | 873.06M |
| March 8, 2013 | 876.68M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
GHDX Market Cap Benchmarks
| Companies | |
|---|---|
| Myriad Genetics | 2.628B |
| Trius Therapeutics | 382.02M |
| Exelixis | 836.30M |
GHDX Market Cap Rankings
| Overall |
1st percentile 1976 of 2003 |
| Sector |
75th percentile 168 of 685 in Healthcare |
| Industry |
69th percentile 20 of 66 in Diagnostics & Research |
GHDX Market Cap Range, Past 5 Years
| Minimum | 352.56M | Jul 21 2010 |
| Maximum | 1.126B | May 17 2013 |
| Average | 679.49M |
